101. Red Cells and Erythropoiesis, Excluding Iron: Poster III

Real world outcomes of patients with cold agglutinin disease

Clinical characterization of the rare G6PD pawnee variant A five patient case series

Vitamin B6 deficiency A cause of unexplained anemia in hospitalized patients in a tertiary care center

AI assisted diagnosis of paroxysmal nocturnal hemoglobinuria

Prednisolone and mycophenolate mofetil as first line therapy in warm autoimmune hemolytic anemia A prospective pilot study

Circulating glycornas A novel class of glycoconjugates in blood and implications for erythrocyte biology

Hereditary spherocytic pyropoikilocytosis Expanding the clinical and genetic spectrum of red blood cell membrane disorders

Treatment with sirolimus for refractory relapsed primary or secondary warm autoimmune hemolytic anemia evans syndrome A single centre prospective study

Early access program for danicopan ALXN2040 as add on treatment to eculizumab or ravulizumab in patients with paroxysmal nocturnal hemoglobinuria PNH Preliminary data from the Italian real world survey

PORT 77 is a potent inhibitor of ABCG2 that reduces efflux of protoporphyrin IX from erythrocytes of patients with protoporphyria and reduces plasma protoporphyrin IX levels in healthy human subjects

Paroxysmal nocturnal hemoglobinuria in pediatric patients A UK experience

Erythropoietin stimulates rapid egress of erythroid and lymphoid cells via the CXCR4–CXCL12 axis

Characteristics at diagnosis of autoimmune hemolytic anemias in adults First results from a prospective multicenter cohort of 413 patients included in the carmen France registry

Pharmacological inhibition of polrmt mimicking polrmt rare variants associated with sideroblastic anemia strongly inhibits proliferation and differentiation of human erythroblasts

Long term outcome and risk factors for relapse in pediatric warm autoimmune hemolytic anemia

Treatment response relapse and survival of hospitalized adult primary warm autoimmune hemolytic anemia A multicenter retrospective cohort study

Long term efficacy and safety of rilzabrutinib an oral bruton tyrosine kinase BTK inhibitor in patients with warm autoimmune hemolytic anemia wAIHA in the LUMINA Phase 2b part B study A 74 week follow up

Efficacy and safety of mitapivat in pediatric patients with pyruvate kinase deficiency who are not regularly transfused Results from the Phase 3 global randomized double blind placebo controlled ACTIVATE Kids trial

Adherence to oral iron in adolescent females with iron deficiency secondary to heavy menstrual bleeding